Nephrology Quiz and Questionnaire: 2009.
Glassock
Richard J
RJ
Department of Medicine, Geffen School of Medicine at UCLA, Los Angeles, California, USA. glassock@cox.net
Bargman
Joanne M
JM
Palmer
Biff F
BF
Samaniego
Millie
M
Fervenza
Fernando C
FC
D000328:Adult; D000617:Aminoglycosides / Q000009:adverse effects; D000686:Amyloidosis / Q000235:genetics; D000890:Anti-Infective Agents / Q000627:therapeutic use; D055499:Catheter-Related Infections / Q000188:drug therapy / Q000382:microbiology; D002408:Catheters, Indwelling / Q000009:adverse effects; D003226:Congresses as Topic; D003924:Diabetes Mellitus, Type 2 / Q000601:surgery; D003928:Diabetic Nephropathies / Q000628:therapy; D005260:Female; D015432:Glomerulonephritis, Membranoproliferative / Q000175:diagnosis; D006084:Graft Rejection / Q000276:immunology; D006417:Hematuria / Q000139:chemically induced; D006463:Hemolytic-Uremic Syndrome / Q000628:therapy; D006801:Humans; D007674:Kidney Diseases / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D007676:Kidney Failure, Chronic / Q000628:therapy; D016030:Kidney Transplantation / Q000009:adverse effects; D054368:Laxatives / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009398:Nephrology; D010530:Peritoneal Dialysis / Q000009:adverse effects; D010538:Peritonitis / Q000188:drug therapy / Q000382:microbiology; D012008:Recurrence; D006435:Renal Dialysis / Q000009:adverse effects / Q000295:instrumentation; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
D000617:Aminoglycosides; D000890:Anti-Infective Agents; D054368:Laxatives